期刊文献+

miR-21慢病毒干扰载体的构建及其对胆管癌细胞增殖和迁移能力的影响 被引量:1

Construction of lentiviral vector knocking down miR-21 and its effects on proliferation and migration of cholangiocarcinoma cell
原文传递
导出
摘要 目的构建miR-21慢病毒干扰载体,并观察其对胆管癌细胞增殖和迁移能力的影响。方法针对目标序列,设计2条合适的PCR引物进行退火得到插入片段序列。将慢病毒干扰载体双酶切,纯化后与退火产物进行定向连接,产生慢病毒干扰质粒和阴性对照质粒,将其与慢病毒包装质粒混合物共转染293T,包装产生慢病毒。使用收获的慢病毒感染胆管癌细胞HUCCT1,荧光显微镜观察感染效率,细胞增殖和划痕实验分别检测HUCCT1下调miR-21后细胞增殖能力和迁移能力的改变。结果成功构建了miR-21慢病毒干扰载体。感染胆管癌细胞HUCCT1后,miR-21表达降低;下调miR-21(LV-anti-miR21)组和感染空白慢病毒载体(LV-GFP)组相比,LV-anti-miR21组增殖能力和迁移能力均明显下降(P<0.05)。结论成功构建miR-21慢病毒干扰载体;下调miR-21能够抑制胆管癌细胞的增殖,降低胆管癌细胞的迁移能力。 Objective To constrcuct a lentiviral vector knocking down miR-21 and observe the effects of knocking down miR-21 on the proliferation and migration of cholangiocarcinoma cells.Methods To get the inserted fragment,2 suitable PCR primers were annealed targeting the sequence.The LV-anti-miR21 and LV-GFP vector were generated by the connection of the purified lentiviral vector and annealing product.The 293T cells were cotransfected with the lentiviral vector and the lentiviral-packaged plasmids to package the recombinant lentivirus.HUCCT1 cholangiocarcinoma cells were infected with recombinant lentivirus.The infection efficiency was observed by fluorescence microscopy.The scratch test and cell proliferation assays were used to detect the changes in cell migration and proliferation after miR-21 was knocked down.Results The lentiviral vector knocking down miR-21 was successfully constructed.HUCCT1 cholangiocarcinoma cells expressed lower miR-21 after infected by the recombinant lentivirus.Compared with the LV-GFP group,the proliferation and migration of LV-anti-miR21 group was significantly reduced(P0.05).ConclusionThe recombinant lentivirus knocking down miR-21 has been constructed successfully.Knocking down miR-21 can inhibit the proliferation and invasiveness of cholangiocarcinoma cells.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第22期2646-2649,F0003,共5页 Jiangsu Medical Journal
关键词 胆管癌 MIR-21 慢病毒 Cholangiocarcinoma miR-21 Lentivirus
  • 相关文献

参考文献2

二级参考文献66

  • 1Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11:1753-1761.
  • 2Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science 2005; 309:1519-1524.
  • 3Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
  • 4Fitzgerald K. RNAi versus small molecules: different mechanisms and specificities can lead to different outcomes. Curr Opin Drug Discov Dev 2005, 8:557-566.
  • 5Brennecke J, Stark A, Russell R.B, Cohen SM. Principles of microRNA-target recognition. PLoS Biol.2005; 3:e85.
  • 6Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122:6-7.
  • 7Chen CZ, Li L, Lodish HF, Bartel DE MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83- 86.
  • 8Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94:776-780.
  • 9Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006; 16:4-9.
  • 10Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.

共引文献209

同被引文献9

  • 1魏矿荣,曾志灵,林建友,梁智恒,郑婉碧.中山市1970-1999年乳腺癌发病动态分析[J].中山大学学报(医学科学版),2004,25(B07):379-381. 被引量:7
  • 2Asangani IA,Rasheed SA,Nikolova DA,et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor PDCD4and stimulates invasion,intravasation and metastasis in colorectal cancer[J].Oncogene,2008,27(15):2128-2136.
  • 3Calin GA,Sevignani C,Dumitru CD,et al.Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J].Proc Natl Acad Sci USA,2004,101(9):2999-3004.
  • 4Lu J,Getz G,Miska EA,et al.MicroRNA expression profiles classify human cancers[J].Nature,2005,435(7043):834-838.
  • 5Qian B,Katsaros D,Lu L,et al.High miR-21expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1[J].Breast Cancer Res Treat,2009,117(1):131-140.
  • 6Si ML,Zhu S,Wu H,et al.miR-21-mediated tumor growth[J].Oncogene,2007,26(19):2799-2803.
  • 7Allgayer H.PDCD4 a colon cancer prognostic that is regulated by a microRNA[J].Crit Rev Oncol Hematol,2010,73(3):185-191.
  • 8Fujita S,Ito T,Mizutani T,et al.miR-21gene expression triggered by AP-1is sustained through a double-negative feedback mechanism[J].J Mol Biol,2008,378(3):492-504.
  • 9Sheedy FJ,Palsson-McDermott E,Hennessy EJ,et al.Negative regulation of TLR4via targeting of the proinflammatory tumor suppressor PDCD4by the microRNA miR-21[J].Nat Immunol,2010,11(2):141-147.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部